| Association of cerebrospinal fluid neurofilament light protein levels with cognition in patients with dementia, motor neuron disease, and movement disorders B Olsson, E Portelius, NC Cullen, Å Sandelius, H Zetterberg, ... JAMA neurology 76 (3), 318-325, 2019 | 229 | 2019 |
| Characterization of Parkinson’s disease using blood-based biomarkers: A multicohort proteomic analysis M Posavi, M Diaz-Ortiz, B Liu, CR Swanson, RT Skrinak, ... PLoS medicine 16 (10), e1002931, 2019 | 56 | 2019 |
| AAV-mediated progranulin delivery to a mouse model of progranulin deficiency causes T cell-mediated toxicity DA Amado, JM Rieders, F Diatta, P Hernandez-Con, A Singer, JT Mak, ... Molecular Therapy 27 (2), 465-478, 2019 | 54 | 2019 |
| Hepatitis C cascade of care in the direct-acting antivirals era: a meta-analysis P Hernandez-Con, DL Wilson, H Tang, I Unigwe, M Riaz, N Ourhaan, ... American journal of preventive medicine, 2023 | 7 | 2023 |
| Course of impulse control disorder symptoms in Parkinson's disease: deep brain stimulation versus medications P Hernandez‐Con, I Lin, E Mamikonyan, W Deeb, R Feldman, A Althouse, ... Movement Disorders Clinical Practice 10 (6), 903-913, 2023 | 5 | 2023 |
| Association of cerebrospinal fluid neurofilament light protein levels with cognition in patients with dementia, motor neuron disease, and movement disorders. JAMA Neurol 76 … B Olsson, E Portelius, NC Cullen, A Sandelius, H Zetterberg, ... | 5 | 2019 |
| Clinician barriers, perceptions, and practices in treating patients with hepatitis C virus and substance use disorder in the United States H Park, C Brown, DL Wilson, PL Huang, P Hernández-Con, P Horne, ... Preventive Medicine Reports 32, 102138, 2023 | 3 | 2023 |
| Nationwide trends in hospitalization, medical costs, and mortality for asthma after introduction of biologics: A cross-sectional study in the United States HR Kang, P Hernandez-Con, JH Heo, DL Wilson, KV Blake, JE Lang, ... Journal of managed care & specialty pharmacy 29 (7), 721-731, 2023 | 2 | 2023 |
| Elucidating the association between direct-acting antivirals and Parkinson's disease in patients with hepatitis C virus infection P Hernandez-Con, R Desai, D Nelson, H Park Parkinsonism & Related Disorders 123, 106557, 2024 | | 2024 |
| Dopamine agonists and risk of lung cancer in patients with restless legs syndrome P Hernandez‐Con, J Shults, AW Willis, YX Yang Pharmacoepidemiology and drug safety 32 (7), 726-734, 2023 | | 2023 |
| Prescription patterns in patients with incident trigeminal neuralgia P Hernandez-Con, H Park, M Maguire, S Keshwani, J Hincapie-Castillo PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 47-47, 2022 | | 2022 |
| The care cascade of hepatitis C virus in the direct-acting antiviral era: A systematic review and meta-analysis P Hernandez-Con, HJ Song, I Unigwe, M Riaz, N Ourhaan, X Jiang, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 403-403, 2022 | | 2022 |
| AAV-mediated progranulin delivery to a mouse model of progranulin deficiency causes T cell-mediated hippocampal degeneration DA Amado, JM Rieders, F Diatta, P Hernandez-Con, A Singer, J Zhang, ... bioRxiv, 308692, 2018 | | 2018 |
| Clinician Barriers, Perceptions, and Practices in Treating Patients with Hepatitis C Virus and Substance Use Disorder H Park, C Brown, DL Wilson, PL Huang, P Hernandez-Con, P Horne, ... Perceptions, and Practices in Treating Patients with Hepatitis C Virus and …, 0 | | |
